tiprankstipranks
Trending News
More News >
Biocryst Pharmaceuticals (BCRX)
NASDAQ:BCRX

Compare BioCryst (BCRX) vs. Competitors

Compare
2,652 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
BioCryst
$6.75
$1.49B
-142.71
-6.22%
8 Buy
2 Hold
0 Sell
Strong Buy
Vericel
$37.05
$1.85B
153.86
-36.37%
4 Buy
1 Hold
0 Sell
Strong Buy
Celldex
$25.93
$1.71B
-7.67
14.82%
9 Buy
0 Hold
1 Sell
Strong Buy
Sarepta Therapeutics
$21.46
$2.22B
-7.42
-80.81%
5 Buy
10 Hold
4 Sell
Hold
Aurinia Pharmaceuticals
$14.99
$2.01B
26.72
101.72%
3 Buy
3 Hold
0 Sell
Moderate Buy
Cidara Therapeutics
$221.38
$6.96B
-18.79
789.79%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
BCRX
BioCryst
6.78
-0.28
-3.97%
VCEL
Vericel
37.33
-19.02
-33.75%
CLDX
Celldex
26.34
3.58
15.73%
SRPT
Sarepta Therapeutics
22.80
-94.26
-80.52%
AUPH
Aurinia Pharmaceuticals
15.23
7.49
96.77%
CDTX
Cidara Therapeutics
221.38
200.13
941.79%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts